(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Theseus Pharmaceuticals, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Wednesday, April 26th, 2023 | 2021 | David P. Kerstein, M.D. Chief Medical Officer | 409,667 | 0 | 0 | 163,330 | 0 | 1,059,081 |
| Wednesday, April 26th, 2023 | 2022 | Timothy P. Clackson, Ph.D. President, Chief Executive Officer and Director | 570,000 | 0 | 0 | 313,500 | 16,790 | 4,351,340 |
| Wednesday, April 26th, 2023 | 2021 | Timothy P. Clackson, Ph.D. President, Chief Executive Officer and Director | 372,239 | 0 | 0 | 195,640 | 0 | 6,969,059 |
| Wednesday, April 26th, 2023 | 2022 | William C. Shakespeare, Ph.D. Co-Founder, President of Research and Development | 465,000 | 0 | 0 | 186,000 | 15,685 | 2,047,105 |
| Wednesday, April 26th, 2023 | 2021 | William C. Shakespeare, Ph.D. Co-Founder, President of Research and Development | 452,038 | 0 | 0 | 188,555 | 0 | 1,752,648 |
| Wednesday, April 26th, 2023 | 2022 | David P. Kerstein, M.D. Chief Medical Officer | 465,000 | 0 | 0 | 186,000 | 16,790 | 1,818,140 |
| Monday, April 25th, 2022 | 2021 | Iain D. Dukes, MA, D.Phil. Co-Founder, Chairman, Director and Former Chief Executive Officer | 99,519 | 30,000 | 0 | 44,000 | 82,830 | 900,828 |
| Monday, April 25th, 2022 | 2020 | Iain D. Dukes, MA, D.Phil. Co-Founder, Chairman, Director and Former Chief Executive Officer | 183,000 | 0 | 0 | 0 | 0 | 1,449,346 |
| Monday, April 25th, 2022 | 2020 | William C. Shakespeare, Ph.D. Co-Founder, President of Research and Development | 323,237 | 0 | 0 | 0 | 0 | 1,589,583 |
| Monday, April 25th, 2022 | 2021 | Bradford D. Dahms | 248,208 | 0 | 0 | 108,638 | 0 | 1,924,747 |
| Monday, April 25th, 2022 | 2021 | Timothy P. Clackson, Ph.D. | 372,239 | 0 | 0 | 195,640 | 0 | 6,969,059 |
| Monday, April 25th, 2022 | 2021 | William C. Shakespeare, Ph.D. Co-Founder, President of Research and Development | 452,038 | 0 | 0 | 188,555 | 0 | 1,752,648 |
